医学
心悸
粘液瘤
单中心
心室
外科
心脏肿瘤
心脏外科
放射科
内科学
作者
Luca Restivo,Antonio De Luca,Enrico Fabris,Linda Pagura,Alessandro Pierri,Renata Korcova,Ilaria Franzese,Alessandro Fiocco,Elisabetta Rauber,Enzo Mazzaro,Rossana Bussani,Manuel Belgrano,Aniello Pappalardo,Gianfranco Sinagra
出处
期刊:Journal of Cardiovascular Medicine
[Ovid Technologies (Wolters Kluwer)]
日期:2022-08-31
卷期号:23 (11): 722-727
被引量:3
标识
DOI:10.2459/jcm.0000000000001375
摘要
Cardiac tumors are rare and heterogeneous entities which still remain a diagnostic and therapeutic challenge. The treatment for most cardiac tumors is prompt surgical resection. We sought to provide an overview of surgical results from a series of consecutive patients treated at our tertiary care center during almost a 20-year experience.In this single center study, 55 consecutive patients with diagnosis of cardiac tumor underwent surgical treatment from January 2002 to April 2021. Of these, 23 (42%) were male and the mean age was 62 ± 12 years. Fifteen (27%) patients were symptomatic at the time of the diagnosis, mostly for dyspnea and palpitations. The most frequent benign cardiac tumor was myxoma (32; 58%), occurring mainly in the left atrium (31; 97%). Pleomorphic sarcoma was the most frequent primary malignant cardiac tumor (4; 7%), mainly located in the ventricles (1; 25% in the left ventricle; 2; 50% in the right ventricle). In all cases of benign tumors surgery was successful with no relapses. Two (50%) pleomorphic sarcomas showed subsequent relapses. After a median follow-up of 44 months, 15 (27%) patients died. Although malignant tumors presented a limited survival, benign tumors showed a very good prognosis.Cardiac tumors require a multidisciplinary approach to guarantee a prompt diagnosis and appropriate treatment. In our surgical experience, outcome after surgery of benign tumors was excellent, while malignant tumors had poor prognosis despite radical surgery.
科研通智能强力驱动
Strongly Powered by AbleSci AI